Multinational life-sciences firm to create 100 jobs in Cork

9 Jul 2010

Eli Lilly, one of the world’s top pharmaceutical firms, is to create 100 new finance jobs in Cork over the next 12 months.

The announcement was made today by the Minister for Enterprise, Trade and Innovation, Batt O’Keeffe TD. Recruitment will begin immediately, and it is expected that most of the new jobs will be filled by spring.

Eli Lilly, which is headquartered in Indianapolis, Indiana, and employs almost 40,000 workers worldwide, has been manufacturing pharmaceutical products in Kinsale since 1981. The new positions will be in a European financial services centre based in Cork city, supporting Eli Lilly’s European operations, providing general accounting, order-to-cash and purchase-to-pay activities.

Minister comments on new jobs for Cork

“The Government has worked closely with Eli Lilly to secure this investment in Cork and the firm’s decision to invest in the county attests strongly to the academic calibre of the local labour pool and the quality of our higher education institutions. The Cork team deserves high praise for attracting this new investment for Ireland.

“Eli Lilly is a firm known the world over for high standards of quality and innovation in pharmaceutical products. We have shown again to the world that we can attract strategic investments from leading multinationals by providing the right mix of skills, workforce flexibility and pro-business policies to support business expansion plans and create jobs for our people,” said O’Keeffe.

“The decision to locate this important operation in Cork was based on our track record here, the availability of a skilled workforce, language ability and the presence of a strong shared services base here in Ireland.

“We look forward to continuing our success in Ireland with this new venture. We recognise and appreciate the continued support and partnership of IDA Ireland as we extend Lilly’s footprint in Ireland,’ said Kay Flynn, senior finance director, European Shared Services, Eli Lilly.

Barry O’Leary, chief executive of IDA Ireland, also welcomed the announcement. “This investment is strategically important to Ireland and Eli Lilly and it is a welcome addition to the growing number of leading pharmaceutical companies that have recognised the benefits of locating financial shared services centres here.

“Today’s announcement by the company fits neatly with IDA Ireland’s Horizon 2020 strategy – IDA Ireland places a strong focus on winning services-based investment and assisting companies to win new international mandates for Ireland, strengthening their strategic importance to their parent company,” he said.

Loading now, one moment please! Loading